Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 22, 2023 13:30 ET | Source: bioLytical Laboratories Inc.

bioLytical Laboratories Inc. Donates Tests to Help Boost International Testing Access Ahead of International Testing Week

bioLytical Laboratories Inc. and NGO Coalition Plus Lead the Charge to Promote the Importance of Rapid Testing during International Testing Week
October 13, 2023 07:30 ET | Source: Theratechnologies

Theratechnologies présente à l’ID Week des données montrant que la tésamoréline réduit le tissu adipeux viscéral et l’accumulation de graisse dans le foie chez les personnes vivant avec le VIH et traitées par des inhibiteurs de l’intégrase (INSTI)

La réduction significative de l’accumulation du tissu adipeux viscéral associée aux INSTI obtenue avec la tésamoréline contraste avec l’augmentation de ce tissu observée chez les patients prenant un...
October 13, 2023 07:30 ET | Source: Theratechnologies

Theratechnologies Presents Data at ID Week Showing Tesamorelin Reduces Visceral Adipose Tissue (VAT) and Liver Fat in People with HIV on Integrase Inhibitors (INSTIs)

Significant reduction in INSTI-associated VAT accumulation with tesamorelin contrasts with VAT increase in patients taking placebo VAT accumulation observed after 12 months on...
February 07, 2023 06:09 ET | Source: Biz2Credit

Biz2Credit Small Business Lending Index™ Reports Growth in Business Loan Approval Rates at Non-Bank Lenders in January 2023

NEW YORK, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Small business loan approval percentages at big banks slipped again, falling from 14.5% in December to 14.4% in January 2023, according to the latest...
June 09, 2022 07:00 ET | Source: Exavir Therapeutics

Exavir Therapeutics announces publication of preclinical data for ultra-long-acting dolutegravir prodrug XVIR-120

Ultra-long-acting plasma pharmacokinetics and biodistribution to tissues of interest demonstrated in three species Injections were well tolerated with no adverse findings in preliminary toxicology...